What is XAGEW's health score?

Longevity Health Holdings, Inc. (XAGEW) has a TradeApes health score of 47 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is XAGEW's estimated fair value?

Based on our 5-year discounted cash flow model, Longevity Health Holdings, Inc.'s estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is XAGEW undervalued or overvalued?

Our model currently rates XAGEW as Fair Value. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for XAGEW... Refresh in a moment for the full analysis.

Longevity Health Holdings, Inc. (XAGEW)

Healthcare Fair Value Medium mixed

Updated: 2026-04-21

TradeApes Score

hold

Financial Strength

25 Stressed

Operating Trend

83 Strong

Relative Value

60 Healthy

Capital Allocation

10 Stressed

Risk

35 Weak

Key Findings

+ Historically cheap — EV/EBITDA in bottom 25% of its 5-year range

Unlock Full Report →

− Weak interest coverage — earnings barely cover debt service

Unlock Full Report →

4 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.